http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105833344-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-16 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L89-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 |
| filingDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105833344-B |
| titleOfInvention | A kind of injection aquagel is preparing the application in Ocular tamponades |
| abstract | The invention discloses the applications in a kind of injection aquagel within the eye filler, it is characterized in that being used as Ocular tamponades application in vitrectomy, and as intraocularly with drug carrier application；The injection aquagel is formed by two doses, first dose is the glue containing oxidation of polysaccharides, second dose is the glue containing chitin derivativ and/or collagen, two doses are respectively charged into two injection-tubes of Double-body syringe, two doses of glues are injected simultaneously through Double-body syringe, it is mixed, is crosslinked in bolus infusion processes, is i.e. the dialdehyde base of oxidation of polysaccharides is crosslinked with the amino of chitin derivativ and/or collagen to react, and being formed has viscoelastic hydrogel.The constituent of hydrogel of the invention is large biological molecule, is different from chemical macromolecule, and also without introducing small molecule crosslinking agent, good biocompatibility, degradable absorption has no toxic side effect, and safety is good. |
| priorityDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.